Shopping Cart (0)
My Account

Shopping Cart
SELECTBIO Conferences 3D-Culture, Organoids & Tox Screening Europe 2019

Peter Ertl's Biography



Peter Ertl, Professor of Lab-on-a-Chip Systems, Vienna University of Technology

Prof. Ertl holds an engineering degree in Biotechnology (University of Life Sciences, Austria), a PhD in Chemistry (Universtiy of Waterloo, Canada) and received his postdoctoral training as a biophysicist at University of California at Berkeley (US). In 2003 Dr. Ertl co-founded a biotech start-up company, where he served a number of years as Director of Product Development in Kitchener (Canada) developing benchtop-sized microbial analyzers. In 2006 Dr. Ertl moved to Austria where he worked as Senior Scientist in the Biosensor Technology unit at the Austrian Institute of Technology (AIT). During his tenure at AIT, Dr. Ertl was also granted a Fulbright Visiting Scholarship at UC Berkeley and conducted visiting scientist positions at Nanyang Technological University, Singapore in 2013 and the Medical Center of the University of California at San Francisco in 2014. In 2016 he was appointed Professor of Lab-on-a-Chip Systems for Bioscience Technologies at the Vienna University of Technology, where his research focuses on the development of advanced in vivo and in vitro diagnostic microsystems.

Peter Ertl Image

Formation, Cultivation and Analysis of 3D Microtissues using a Microfluidic Multicellular Spheroid Array

Friday, 14 June 2019 at 12:00

Add to Calendar ▼2019-06-14 12:00:002019-06-14 13:00:00Europe/LondonFormation, Cultivation and Analysis of 3D Microtissues using a Microfluidic Multicellular Spheroid Array3D-Culture, Organoids and Tox Screening Europe 2019 in Rotterdam, The NetherlandsRotterdam, The NetherlandsSELECTBIOenquiries@selectbiosciences.com

A long-standing trend in pharmaceutical development, toxicology and biomedicine has been the establishment of complex in vitro 3D cell cultures whose structures and function resemble human tissues. To meet the growing need to improve the predictive power of toxicological, pharmaceutical and preclinical studies, the multicellular spheroid array builds on the advancement of novel organ-on-a-chip technology that establishes, cultivates and supports a wide variety of multicellular spheroids (3D cell aggregates). This system thus closes an important technological gap, enabling rapid and easy production of spheroids of defined size and cell types.


Add to Calendar ▼2019-06-13 00:00:002019-06-14 00:00:00Europe/London3D-Culture, Organoids and Tox Screening Europe 20193D-Culture, Organoids and Tox Screening Europe 2019 in Rotterdam, The NetherlandsRotterdam, The NetherlandsSELECTBIOenquiries@selectbiosciences.com